FocusPolicy Tuberculosis vaccines: Time for a global strategy Stefan H. E. Kaufmann1,*, Thomas G. Evans2 and Willem A. Hanekom31Department of Immunology, Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.2Aeras, Rockville, MD 20850, USA.3Bill & Melinda Gates Foundation, Seattle, WA 98109, USA.↵*Corresponding author. E-mail: kaufmann{at}mpiib-berlin.mpg.de See allHide authors and affiliations Science Translational Medicine 25 Feb 2015:Vol. 7, Issue 276, pp. 276fs8DOI: 10.1126/scitranslmed.aaa4730 Stefan H. E. Kaufmann 1Department of Immunology, Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: kaufmann@mpiib-berlin.mpg.de Thomas G. Evans 2Aeras, Rockville, MD 20850, USA.Find this author on Google Scholar Find this author on PubMed Search for this author on this site Willem A. Hanekom 3Bill & Melinda Gates Foundation, Seattle, WA 98109, USA.Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Figures & Data Info & Metrics eLetters PDF Abstract We need a global strategy for the development of better tuberculosis vaccines. Copyright © 2015, American Association for the Advancement of ScienceView Full Text
Tuberculosis vaccines: Time for a global strategy By Stefan H. E. Kaufmann, Thomas G. Evans, Willem A. Hanekom Science Translational Medicine25 Feb 2015 : 276fs8 We need a global strategy for the development of better tuberculosis vaccines.
Tuberculosis vaccines: Time for a global strategy By Stefan H. E. Kaufmann, Thomas G. Evans, Willem A. Hanekom Science Translational Medicine25 Feb 2015 : 276fs8 We need a global strategy for the development of better tuberculosis vaccines.